Early, awake proning in emergency department patients with COVID-19

Nicole M Dubosh, Matthew L Wong, Anne V Grossestreuer, Ying K Loo, Leon D Sanchez, David Chiu, Evan L Leventhal, Annette Ilg, Michael W Donnino, Nicole M Dubosh, Matthew L Wong, Anne V Grossestreuer, Ying K Loo, Leon D Sanchez, David Chiu, Evan L Leventhal, Annette Ilg, Michael W Donnino

Abstract

Objective: Proning has been shown to improve oxygenation and mortality in certain populations of intubated patients with acute respiratory distress syndrome. Small observational analyses of COVID-19 patients suggest awake proning may lead to clinical improvement. Data on safety and efficacy is lacking. We sought to describe the effect of proning on oxygenation in nonintubated COVID-19 patients. We also evaluated feasibility, safety, and other physiological and clinical outcomes associated with this intervention.

Methods: We conducted a prospective, observational cohort study of nonintubated patients with COVID-19 who underwent proning per an Emergency Department (ED) clinical protocol. Patients with mild to moderate respiratory distress were included. We calculated change in oxygenation by comparing the oxygen saturation to fraction of inspired oxygen ratio (SpO2:FiO2) during the five minutes prior to proning and first 30 min of proning. We also captured data on respiratory rate, duration of proning, need for intubation, intensive care unit admission, survival to discharge.

Results: Fifty-two patients were enrolled. Thirty were excluded for not meeting protocol inclusion criteria or missing baseline oxygenation data, leaving 22 for analysis. The SpO2:FiO2 ratio increased by a median of 5 (IQR: 0-15) in the post-proning period compared to the pre-proning period (median: 298 (IQR: 263-352) vs 295 (IQR: 276-350), p = 0.01). Respiratory rate did not change significantly between time periods. No immediate adverse events occurred during proning. Five patients (23%) were intubated within 48 h of admission.

Conclusion: Early, awake proning may be feasible in select COVID-19 patients and was associated with improved oxygenation.

Keywords: COVID-19; Feasibility; Proning.

Conflict of interest statement

Declaration of Competing Interest None.

Copyright © 2020. Published by Elsevier Inc.

Figures

Fig. 1
Fig. 1
Flow Chart of Patient Selection for ED Proning Protocol.

References

    1. Guerin C., Reignier J., Richard J., et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159–2168. doi: 10.1056/NEJMoa1214103.
    1. Gattinoni L., Carlesso E., Taccone P., et al. Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis. Minerva Anestesiol. 2010;76:448–454.
    1. Valesky W., Chow L. Prone positioning for acute respiratory distress syndrome in adults. Acad Emerg Med. 2020 doi: 10.1111/acem.13948.
    1. Dickinson S., Park P.K., Napolitano L.M. Post-position therapy in ARDS. Crit Care Clin. 2011;27:511–523. doi: 10.1016/j.ccc.2011.05.010.
    1. Gattinoni L., Taccone P., Carlesso E., Marini J.J. Prone position in acute respiratory distress syndrome. Rationale, indications, and limits. Am J Respir Crit Care Med. 2013;188:1286–1293. doi: 10.1164/rccm.201308-1532CI.
    1. Scaravilli V., Grasselli G., Castagna L., et al. Prone positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study. J Crit Care. 2015;30:1390–1394. doi: 10.1016/j.jcrc.2015.07.008.
    1. Gattinoni L., Coppola S., Cressoni M., Busana M., Chiumello D. Covid-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201:1299–1300. doi: 10.1164/rccm.202003-0817LE.
    1. Gattinoni L., Chiumello D., Camporota, et al. COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive Care Med. 2020 doi: 10.1007/s00134-020-06033-2.
    1. Sun Q., Qiu H., Huang M., et al. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020;10:33. doi: 10.1186/s13613-020-00650-2.
    1. Slessarev M., Cheng J., Ondrejicka M., Arntfield R. Patient self-proning with high-flow nasal cannula improves oxygenation in COVID-19 pneumonia. Can J Anesth. 2020 doi: 10.1007/s12630-020-01661-0.
    1. EMRAP LIVE: COVID19 Update March 31. 2020. GLbKyc31XhM&t=3192s. Accessed March 31, 2020.
    1. EMRAP LIVE: COVID19 Update April 28. 2020. Accessed April 29, 2020.
    1. Weingart S.D. 2020. COVID19 – awake pronation (aka the pig roast) a guest write-up by David Gordon, MD EMCrit Podcast April 6. Accessed April 7, 2020.
    1. Caputo N.D., Strayer R.J., Levitan R. Early self-proning in awake, non-intubated patients in the emergency department: a single ED’s experience during the COVID-19 pandemic. Acad Emerg Med. 2020;27:375–378. doi: 10.1111/acem.13994.
    1. Thompson A.E., Ranard B.L., Wei Y., Jelic S. Prone positioning in awake, nonintubated patients with COVID-19 hypoxemic respiratory failure. JAMA Intern Med. 2020 Jun 17 doi: 10.1001/jamainternmed.2020.3030.
    1. Elharrar X., Trigui Y., Dols A.M., et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA. 2020;323:2336–2338. doi: 10.1001/jama.2020.8255.
    1. von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349. doi: 10.1016/j.jclinepi.2007.11.008.
    1. Moskowitz A., Yankama T., Andersen L.W., et al. Ascorbic acid, corticosteroids, and thiamine in sepsis (ACTS) protocol and statistical analysis plan: a prospective, multicenter, double-blind, randomized, placebo-controlled clinical trial. BMJ Open. 2019;9 doi: 10.1136/bmjopen-2019-034406.
    1. Ding L., Wang L., Ma W., et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care. 2020;24:28. doi: 10.1186/s13054-020-2738-5.
    1. Frat J.P., Thille A.W., Mercat A., et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185–2196. doi:0.1056/NEJMoa1503326.
    1. Ziehr D.R., Alladina J., Petri C.R., et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med. 2020 doi: 10.1164/rccm.202004-1163LE.
    1. Hui D.S., Chow B.K., Lo T., et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different face masks. Eur Respir J. 2019;53:1802339. doi: 10.1183/13993003.02339-2018.
    1. Li J., Fink J.B., Ehrmann S., et al. High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion. Eur Respir J. 2020;55:2000892. doi: 10.1183/13993003.00892-2020.
    1. Bauer P.R., Gajic O., Nanchal R., et al. Association between timing of intubation and outcome in critically ill patients: a secondary analysis of the ICON audit. J Crit Care. 2017;42:1–5. doi: 10.1016/j.jcrc.2017.06.010.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit